"Starting this year, we're investing more in Alzheimer's disease, particularly moderate to severe Alzheimer's, but also in the entire disease, to catch patients as early as possible and also begin to raise awareness about their treatment." This was stated by Giulia Pesce, Brand Manager for Lusofarmaco, speaking at the 56th Congress of the Italian Society of Neurology (SIN), held from October 24 to 27, 2026, in Florence.
https://www.youtube.com/watch?v=zKNaGf-FB0g
